241 related articles for article (PubMed ID: 20619255)
1. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
[TBL] [Abstract][Full Text] [Related]
2. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
3. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
4. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
6. Determination of a steroid profile in heel prick blood using LC-MS/MS.
Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
[TBL] [Abstract][Full Text] [Related]
7. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
[TBL] [Abstract][Full Text] [Related]
8. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
[TBL] [Abstract][Full Text] [Related]
9. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
10. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
[TBL] [Abstract][Full Text] [Related]
12. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.
Dhillon K; Ho T; Rich P; Xu D; Lorey F; She J; Bhandal A
Clin Chim Acta; 2011 Nov; 412(23-24):2076-84. PubMed ID: 21803033
[TBL] [Abstract][Full Text] [Related]
13. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
[TBL] [Abstract][Full Text] [Related]
15. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.
Güran T; Tezel B; Çakır M; Akıncı A; Orbak Z; Keskin M; Selver Eklioğlu B; Ozon A; Özbek MN; Karagüzel G; Hatipoğlu N; Gürbüz F; Çizmecioğlu FM; Kara C; Şimşek E; Baş F; Aydın M; Darendeliler F
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):287-294. PubMed ID: 32157855
[TBL] [Abstract][Full Text] [Related]
17. Dried Blood Spot Multiplexed Steroid Profiling Using Liquid Chromatography Tandem Mass Spectrometry in Korean Neonates.
Choi R; Park HD; Oh HJ; Lee K; Song J; Lee SY
Ann Lab Med; 2019 May; 39(3):263-270. PubMed ID: 30623618
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
Grecsó N; Zádori A; Baráth Á; Galla Z; Rácz G; Bereczki C; Monostori P
PLoS One; 2021; 16(5):e0252091. PubMed ID: 34015037
[TBL] [Abstract][Full Text] [Related]
19. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia.
Sarafoglou K; Banks K; Gaviglio A; Hietala A; McCann M; Thomas W
Pediatrics; 2012 Nov; 130(5):e1261-8. PubMed ID: 23071209
[TBL] [Abstract][Full Text] [Related]
20. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
